BTG (BTG)

 

BTG Share PerformanceMore

52 week high739.5 12/07/16
52 week low528.4 31/01/17
52 week change 39.0 (5.99%)
4 week volume17,129,850 01/06/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Holding(s) in Company

RNS Number: 0582J BTG PLC 23 June 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii BTG plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of qualif...

Holding(s) in Company

RNS Number: 7210I BTG PLC 21 June 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii BTG plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of qualify...

Price Monitoring Extension

RNS Number: 3830I BTG PLC 16 June 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price...

Study demonstrates efficacy of EKOS therapy, says BTG

BTG has highlighted trial results which showed that patients with post-thrombotic syndrome can be treated safely and eff...

ACCESS PTS Study Shows Efficacy of EKOS? Therapy

RNS Number: 9604H BTG PLC 16 June 2017 ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome Bothell, WA, 16 June 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the ACCESS PTS trial , presented at the Society for Vascular Medicine 28 th Annual Scientific Sessions in Ne...

BTG confirms date of AGM

BTG has confirmed that it intends to hold its Annual General Meeting on 13 July. At 2:26pm: (LON:BTG) BTG PLC share p...

Annual Financial Report

RNS Number: 9705H BTG PLC 13 June 2017 BTG plc 13 June 2017 ANNUAL REPORT AND ACCOUNTS 2017 In accordance with the Listing Rule 9.6.1, copies of the following documents have been submitted to the UK Listing Authority and will shortly be available for inspection via the National Storage Mechanism at http://www.morningstar.co.uk/uk/NSM A copy...

Director Deals - BTG PLC (BTG)

Rolf Soderstrom, Financial Director, has transferred in 42,624 shares in the company on the 9th June 2017 at a price of 0.00...

Fundamental DataMore

P/E ratio43.671
EPS15.8
Dividend yield0 %

Equity Research (BTG)

edison investment research
BTG plc
08/04/2016
Growth across all three divisions of BTG’s Interventional Medicine (IM) franchise (oncology, vascular and pulmonology), coupled with currency tailwinds, helped push FY16 revenue towards the upper end...
edison investment research
BTG plc
30/11/2015
BTG’s interim results have driven upgrades to our financial forecasts with a small boost to revenues from one-off Zytiga backdated royalties. Our operating expenses are broadly unchanged, but...
edison investment research
BTG plc
30/10/2015
BTG’s close period update saw a revision to its FY16 revenue guidance, targeting sales in the lower half of £410-440m (at $1.61/£). This is based on slower-than-expected Varithena sales, despite a...

Latest discussion posts More

  • Vectura

    Perhaps our increasing SP & rating will tempt The Dame to buy Vectura to put me out of my misery & increase my decent holding here substantially !
    23-Jun-2017
    dave297
  • Cor

    Coooore blimey governore apparently some spivs are shorting or snorting the stock hey ho love and kisses from a long term btg holder
    17-Jun-2017
    up protherics
  • ACCESS PTS study meet eligibility

    This is more good news for BTG and our EKOS therapy . BE HAPPY DAVE ACCESS PTS Study Demonstrates Efficacy of EKOS? Therapy for Post-Thrombotic Syndrome Bothell, ...
    16-Jun-2017
    d gaser

Users' HoldingsMore

Users who hold BTG also hold..
LLOYDS GRP.35%
GLAXOSMITHKLINE25%
NATIONAL GRID24%
BP23%
VODAFONE GRP.23%

Codes & Symbols

ISINGB0001001592
SymbolsBTG, LSE:BTG, BTG.L, BTG:LN, LON:BTG, XLON:BTG